Functional Imaging in Hypoxic-Ischemic Retinal Disease

缺氧缺血性视网膜疾病的功能成像

基本信息

  • 批准号:
    10456440
  • 负责人:
  • 金额:
    $ 10.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-01 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary Ischemia and hypoxia play critical roles in the pathophysiology of common blinding diseases such as diabetic retinopathy (DR) and retinal vein occlusions (RVO). Unfortunately, the correlation between impaired capillary perfusion, often called ischemia or “nonperfusion,” and hypoxia is largely unknown in a clinical setting because of limited imaging methodologies. Impaired capillary perfusion is almost exclusively demonstrated in clinic by fluorescein angiography (FA) but histological studies show that FA underestimates capillary density as much as 30-40% thereby under-diagnosing “nonperfusion.” Indirect clinical evidence and animal studies suggest that hypoxia underlies sequelae of DR and RVO. For example, contrast sensitivity deficits and retinal thickening are reversed in diabetic subjects breathing oxygen. However, there is little direct evidence of retinal hypoxia in humans because of the invasive methods needed to measure intraretinal oxygen levels. Since there is no direct clinical measure for mild-moderate hypoxia and only limited assessments of impaired capillary perfusion (ischemia), current treatments for DR and RVO presume a direct and static relationship between these two. However, abundant clinical evidence suggests that ischemia and hypoxia are not directly correlated. These observations confirm that the correlation between ischemia, hypoxia and sequelae of retinal vascular diseases are incompletely understood. I hypothesize that the relationship between microvascular hypoxia and ischemia is not static nor necessarily direct; and I suggest that this underlies limitations in current treatments and therapeutic failures. I propose basic and clinical studies that correlate real time intraocular pO2 measurements in animal models of ischemia with non-invasive imaging methods such as optical coherence tomography angiography (OCTA) to assess retinal capillary perfusion and hyperspectral computed tomographic imaging spectroscopy (HCTIS) to assess tissue hypoxia. These methods are then translated to the clinic where they are already shown to be safe and effective imaging modalities in pilot studies I have performed. The combination of these approaches leverages the gold standard intraocular pO2 measurements to validate and calibrate non- invasive methods that can be used safely and effectively in human subjects. Lastly, I propose to use OCTA and HCTIS to correlate the extent and duration of ischemia and hypoxia in human subjects with vision loss from DR and RVO.
项目概要 缺血和缺氧在常见致盲疾病的病理生理学中发挥着关键作用 例如糖尿病视网膜病变(DR)和视网膜静脉阻塞(RVO)。不幸的是, 毛细血管灌注受损(通常称为缺血或“无灌注”)与 由于成像方法有限,缺氧在临床环境中很大程度上是未知的。 毛细血管灌注受损在临床上几乎完全由荧光素证明 血管造影 (FA) 但组织学研究表明 FA 低估了毛细血管密度 高达 30-40%,因此对“无灌注”的诊断不足。间接临床证据和动物 研究表明缺氧是 DR 和 RVO 后遗症的根源。例如,对比 呼吸氧气的糖尿病患者的敏感性缺陷和视网膜增厚得到了逆转。 然而,由于侵入性视网膜损伤,几乎没有直接证据表明人类视网膜缺氧。 测量视网膜内氧水平所需的方法。由于没有直接的临床测量方法 适用于轻度至中度缺氧以及对毛细血管灌注受损的有限评估 (缺血),目前 DR 和 RVO 的治疗假定存在直接且静态的关系 在这两者之间。然而,大量的临床证据表明缺血和缺氧 不直接相关。这些观察结果证实了缺血之间的相关性, 缺氧和视网膜血管疾病的后遗症尚不完全清楚。我假设 微血管缺氧和缺血之间的关系不是静态的也不一定 直接的;我认为这是当前治疗的局限性和治疗失败的原因。 我建议进行基础和临床研究,将实时眼内 pO2 测量值与 使用光学相干等非侵入性成像方法建立缺血动物模型 断层扫描血管造影 (OCTA) 用于评估视网膜毛细血管灌注和高光谱 计算机断层扫描成像光谱(HCTIS)用于评估组织缺氧。这些 然后将方法转化为临床,它们已被证明是安全有效的 我进行的试点研究中的成像方式。这些方法的结合 利用金标准眼内 pO2 测量来验证和校准非 可以在人类受试者中安全有效地使用的侵入性方法。最后我建议 使用 OCTA 和 HCTIS 关联人体缺血和缺氧的程度和持续时间 因 DR 和 RVO 导致视力丧失的受试者。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography.
  • DOI:
    10.1371/journal.pone.0176404
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Koulisis N;Kim AY;Chu Z;Shahidzadeh A;Burkemper B;Olmos de Koo LC;Moshfeghi AA;Ameri H;Puliafito CA;Isozaki VL;Wang RK;Kashani AH
  • 通讯作者:
    Kashani AH
Surgically Induced Focal Retinal Detachment Does Not Cause Detectable SD-OCT Retinal Changes in Normal Human Retina.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amir H Kashani其他文献

Amir H Kashani的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amir H Kashani', 18)}}的其他基金

Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
多种族人群中影像学和基于血液的小血管 VCID 生物标志物的验证
  • 批准号:
    10611821
  • 财政年份:
    2021
  • 资助金额:
    $ 10.35万
  • 项目类别:
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
大脑健康的多维评估作为痴呆症风险和复原力的标志
  • 批准号:
    10670132
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
大脑健康的多维评估作为痴呆症风险和复原力的标志
  • 批准号:
    10451624
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
大脑健康的多维评估作为痴呆症风险和复原力的标志
  • 批准号:
    10261497
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
使用基于 OCT 血管造影的新型指标评估视网膜血管疾病中的视网膜毛细血管密度、形态和功能
  • 批准号:
    10004661
  • 财政年份:
    2019
  • 资助金额:
    $ 10.35万
  • 项目类别:
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
使用基于 OCT 血管造影的新型指标评估视网膜血管疾病中的视网膜毛细血管密度、形态和功能
  • 批准号:
    10460809
  • 财政年份:
    2019
  • 资助金额:
    $ 10.35万
  • 项目类别:
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
使用基于 OCT 血管造影的新型指标评估视网膜血管疾病中的视网膜毛细血管密度、形态和功能
  • 批准号:
    10245006
  • 财政年份:
    2019
  • 资助金额:
    $ 10.35万
  • 项目类别:
3D OCT Angiography for quantitative characterization of diabetic retinopathy
3D OCT 血管造影定量表征糖尿病视网膜病变
  • 批准号:
    9299870
  • 财政年份:
    2017
  • 资助金额:
    $ 10.35万
  • 项目类别:
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
脑小血管疾病的脑和视网膜微血管成像
  • 批准号:
    9356350
  • 财政年份:
    2016
  • 资助金额:
    $ 10.35万
  • 项目类别:
Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
多种族人群中影像学和基于血液的小血管 VCID 生物标志物的验证
  • 批准号:
    10369505
  • 财政年份:
    2016
  • 资助金额:
    $ 10.35万
  • 项目类别:

相似国自然基金

非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Elucidation of Novel Oxygen-Dependent and Post-Transcriptionally Regulated Genes in Hypoxic Tumour Microenvironments Using Spatial Transcriptomics and Imaging Mass Cytometry
利用空间转录组学和成像质谱流式细胞仪阐明缺氧肿瘤微环境中的新型氧依赖性和转录后调控基因
  • 批准号:
    559095-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 10.35万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Elucidation of Novel Oxygen-Dependent and Post-Transcriptionally Regulated Genes in Hypoxic Tumour Microenvironments Using Spatial Transcriptomics and Imaging Mass Cytometry
利用空间转录组学和成像质谱流式细胞仪阐明缺氧肿瘤微环境中的新型氧依赖性和转录后调控基因
  • 批准号:
    559095-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 10.35万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
  • 批准号:
    9897365
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Elucidation of Novel Oxygen-Dependent and Post-Transcriptionally Regulated Genes in Hypoxic Tumor Microenvironments Using Spatial Transcriptomics and Imaging Mass Cytometry
利用空间转录组学和成像质谱流式细胞仪阐明缺氧肿瘤微环境中的新型氧依赖性和转录后调控基因
  • 批准号:
    552844-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
  • 批准号:
    10544779
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Visualization of breast tumor with its tumor vessel and intratumoral hypoxic region by photoacoustic imaging
乳腺肿瘤及其肿瘤血管和瘤内缺氧区域的光声成像可视化
  • 批准号:
    20K16822
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
  • 批准号:
    10314063
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01 - Revision - 1
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01 - 修订版 - 1
  • 批准号:
    10289582
  • 财政年份:
    2020
  • 资助金额:
    $ 10.35万
  • 项目类别:
Engineering fluorescence and magnetic resonance reporter genes for imaging biological function in hypoxic cells and in vivo
工程化荧光和磁共振报告基因,用于缺氧细胞和体内生物功能成像
  • 批准号:
    10687183
  • 财政年份:
    2019
  • 资助金额:
    $ 10.35万
  • 项目类别:
Engineering fluorescence and magnetic resonance reporter genes for imaging biological function in hypoxic cells and in vivo
工程化荧光和磁共振报告基因,用于缺氧细胞和体内生物功能成像
  • 批准号:
    10266048
  • 财政年份:
    2019
  • 资助金额:
    $ 10.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了